Aberrant promoter methylation and expression of UTF1 during cervical carcinogenesis

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Guenin, Samuel ^a   Mouallif, Mustapha ^a,b   Deplus, Rachel ^c   Lampe, Xavier ^c   Krusy, Nathalie ^a   Calonne, Emilie ^c   Delbecque, Katty ^d   Kridelka, Frederic ^d   Fuks, François ^c   Ennaji, My Mustapha ^b   Delvenne, Philippe ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b HASSAN II UNIVERSITY   (Morocco)

^c FREE UNIVERSITY OF BRUSSELS   (Belgium)

^d UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA METHYLTRANSFERASE; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX2; TUMOR MARKER; UNCLASSIFIED DRUG; UNDIFFERENTIATED CELL TRANSCRIPTION FACTOR 1;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE SEVERITY; DNA METHYLATION; ENZYME INHIBITION; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PYROSEQUENCING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX CARCINOMA; UTERINE CERVIX EPITHELIUM; UTF1 GENE; WESTERN BLOTTING;

AZACITIDINE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; CERVIX UTERI; CLUSTER ANALYSIS; CYTOLOGICAL TECHNIQUES; DNA METHYLATION; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; NEOPLASMS, GLANDULAR AND EPITHELIAL; NEOPLASTIC STEM CELLS; NUCLEAR PROTEINS; OCTAMER TRANSCRIPTION FACTOR-3; OVARIAN NEOPLASMS; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; SOXB1 TRANSCRIPTION FACTORS; TRANS-ACTIVATORS; UTERINE CERVICAL NEOPLASMS;

EID: 84864573024     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042704     Document Type: Article

References (60)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International journal of cancer Journal international du cancer 127: 2893-2917.
2. zur Hausen H, (2009) Papillomaviruses in the causation of human cancers- a brief historical account. Virology 384: 260-265.
3. Hall S, Lorincz A, Shah F, Sherman ME, Abbas F, et al. (1996) Human papillomavirus DNA detection in cervical specimens by hybrid capture: correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix. Gynecologic oncology 62: 353-359.
4. Chik F, Szyf M, Rabbani SA, (2011) Role of epigenetics in cancer initiation and progression. Advances in experimental medicine and biology 720: 91-104.
5. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
6. Reya T, Morrison SJ, Clarke MF, Weissman IL, (2001) Stem cells, cancer, and cancer stem cells. Nature 414: 105-111.
7. Mathieu J, Zhang Z, Zhou W, Wang AJ, Heddleston JM, et al. (2011) HIF induces human embryonic stem cell markers in cancer cells. Cancer research 71: 4640-4652.
8. Feng D, Peng C, Li C, Zhou Y, Li M, et al. (2009) Identification and characterization of cancer stem-like cells from primary carcinoma of the cervix uteri. Oncology reports 22: 1129-1134.
9. Bortolomai I, Canevari S, Facetti I, De Cecco L, Castellano G, et al. (2010) Tumor initiating cells: development and critical characterization of a model derived from the A431 carcinoma cell line forming spheres in suspension. Cell cycle 9: 1194-1206.
10. Liu D, Zhou P, Zhang L, Wu G, Zheng Y, et al. (2011) Differential expression of Oct4 in HPV-positive and HPV-negative cervical cancer cells is not regulated by DNA methyltransferase 3A. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine 32: 941-950.
11. Mueller T, Luetzkendorf J, Nerger K, Schmoll HJ, Mueller LP, (2009) Analysis of OCT4 expression in an extended panel of human tumor cell lines from multiple entities and in human mesenchymal stem cells. Cellular and molecular life sciences: CMLS 66: 495-503.
12. Wang X, Dai J, (2010) Concise review: isoforms of OCT4 contribute to the confusing diversity in stem cell biology. Stem cells 28: 885-893.
13. Pain D, Chirn GW, Strassel C, Kemp DM, (2005) Multiple retropseudogenes from pluripotent cell-specific gene expression indicates a potential signature for novel gene identification. The Journal of biological chemistry 280: 6265-6268.
14. Pellacani D, Packer RJ, Frame FM, Oldridge EE, Berry PA, et al. (2011) Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer. Molecular cancer 10: 94.
15. Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, et al. (2008) CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. The Journal of clinical investigation 118: 2111-2120.
16. Ji J, Zheng PS, (2010) Expression of Sox2 in human cervical carcinogenesis. Human pathology 41: 1438-1447.
17. Xuan YH, Jung HS, Choi YL, Shin YK, Kim HJ, et al. (2006) Enhanced expression of hedgehog signaling molecules in squamous cell carcinoma of uterine cervix and its precursor lesions. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc 19: 1139-1147.
18. Kooistra SM, Thummer RP, Eggen BJ, (2009) Characterization of human UTF1, a chromatin-associated protein with repressor activity expressed in pluripotent cells. Stem cell research 2: 211-218.
19. Wang P, Li J, Allan RW, Guo CC, Peng Y, et al. (2010) Expression of UTF1 in primary and metastatic testicular germ cell tumors. American journal of clinical pathology 134: 604-612.
20. van den Boom V, Kooistra SM, Boesjes M, Geverts B, Houtsmuller AB, et al. (2007) UTF1 is a chromatin-associated protein involved in ES cell differentiation. The Journal of cell biology 178: 913-924.
21. Kristensen DM, Nielsen JE, Skakkebaek NE, Graem N, Jacobsen GK, et al. (2008) Presumed pluripotency markers UTF-1 and REX-1 are expressed in human adult testes and germ cell neoplasms. Human reproduction 23: 775-782.
22. Imamura M, Miura K, Iwabuchi K, Ichisaka T, Nakagawa M, et al. (2006) Transcriptional repression and DNA hypermethylation of a small set of ES cell marker genes in male germline stem cells. BMC developmental biology 6: 34.
23. Melone MA, Giuliano M, Squillaro T, Alessio N, Casale F, et al. (2009) Genes involved in regulation of stem cell properties: studies on their expression in a small cohort of neuroblastoma patients. Cancer biology & therapy 8: 1300-1306.
24. Reinisch CM, Mildner M, Petzelbauer P, Pammer J, (2011) Embryonic stem cell factors undifferentiated transcription factor-1 (UFT-1) and reduced expression protein-1 (REX-1) are widely expressed in human skin and may be involved in cutaneous differentiation but not in stem cell fate determination. International journal of experimental pathology 92: 326-332.
25. Arafa M, Boniver J, Delvenne P, (2008) Detection of HPV-induced cervical (pre) neoplastic lesions: a tissue microarray (TMA) study. Applied immunohistochemistry & molecular morphology: AIMM/official publication of the Society for Applied Immunohistochemistry 16: 422-432.
26. Gunderson KL, Bibikova M, Le J, Barnes B, Saedinia-Melnyk S, et al. (2009) Genome-wide DNA methylation profiling using Infinium (R) assay. Epigenomics 1: 177-200.
27. Gronniger E, Weber B, Heil O, Peters N, Stab F, et al. (2010) Aging and chronic sun exposure cause distinct epigenetic changes in human skin. PLoS genetics 6: e1000971.
28. de Hoon MJ, Imoto S, Nolan J, Miyano S, (2004) Open source clustering software. Bioinformatics 20: 1453-1454.
29. Takahashi Y, Iwai M, Kawai T, Arakawa A, Ito T, et al. (2011) Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of primary breast cancer. Breast cancer doi: 10.1007/s12282-011-0272-7.
30. Herfs M, Hubert P, Suarez-Carmona M, Reschner A, Saussez S, et al. (2010) Regulation of p63 isoforms by snail and slug transcription factors in human squamous cell carcinoma. The American journal of pathology 176: 1941-1949.
31. Zhao S, Yuan Q, Hao H, Guo Y, Liu S, et al. (2011) Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma. The Journal of pathology 223: 672-682.
32. Mosmann T, (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
33. Kahn SL, Ronnett BM, Gravitt PE, Gustafson KS, (2008) Quantitative methylation-specific PCR for the detection of aberrant DNA methylation in liquid-based Pap tests. Cancer 114: 57-64.
34. Dehan P, Kustermans G, Guenin S, Horion J, Boniver J, et al. (2009) DNA methylation and cancer diagnosis: new methods and applications. Expert review of molecular diagnostics 9: 651-657.
35. Wentzensen N, Sherman ME, Schiffman M, Wang SS, (2009) Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. Gynecologic oncology 112: 293-299.
36. Kim JH, Choi YD, Lee JS, Lee JH, Nam JH, et al. (2010) Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens. Gynecologic oncology 116: 99-104.
37. Feng Q, Balasubramanian A, Hawes SE, Toure P, Sow PS, et al. (2005) Detection of hypermethylated genes in women with and without cervical neoplasia. Journal of the National Cancer Institute 97: 273-282.
38. Overmeer RM, Henken FE, Bierkens M, Wilting SM, Timmerman I, et al. (2009) Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis. The Journal of pathology 219: 327-336.
39. Lim EH, Ng SL, Li JL, Chang AR, Ng J, et al. (2010) Cervical dysplasia: assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy. Gynecologic oncology 119: 225-231.
40. Dupont JM, Tost J, Jammes H, Gut IG, (2004) De novo quantitative bisulfite sequencing using the pyrosequencing technology. Analytical biochemistry 333: 119-127.
41. Sun C, Reimers LL, Burk RD, (2011) Methylation of HPV16 genome CpG sites is associated with cervix precancer and cancer. Gynecologic oncology 121: 59-63.
42. Zhao Y, Yin X, Qin H, Zhu F, Liu H, et al. (2008) Two supporting factors greatly improve the efficiency of human iPSC generation. Cell stem cell 3: 475-479.
43. Alison MR, Lim SM, Nicholson LJ, (2011) Cancer stem cells: problems for therapy? The Journal of pathology 223: 147-161.
44. Suva ML, Riggi N, Stehle JC, Baumer K, Tercier S, et al. (2009) Identification of cancer stem cells in Ewing's sarcoma. Cancer research 69: 1776-1781.
45. Cantz T, Key G, Bleidissel M, Gentile L, Han DW, et al. (2008) Absence of OCT4 expression in somatic tumor cell lines. Stem cells 26: 692-697.
46. Nishimoto M, Miyagi S, Yamagishi T, Sakaguchi T, Niwa H, et al. (2005) Oct-3/4 maintains the proliferative embryonic stem cell state via specific binding to a variant octamer sequence in the regulatory region of the UTF1 locus. Molecular and cellular biology 25: 5084-5094.
47. Reinisch CM, Uthman A, Erovic BM, Pammer J, (2007) Expression of BMI-1 in normal skin and inflammatory and neoplastic skin lesions. J Cutan Pathol 34: 174-180.
48. Kooistra SM, van den Boom V, Thummer RP, Johannes F, Wardenaar R, et al. (2010) Undifferentiated embryonic cell transcription factor 1 regulates ESC chromatin organization and gene expression. Stem cells 28: 1703-1714.
49. Zhao Z, Fan L, Frick KM, (2010) Epigenetic alterations regulate estradiol-induced enhancement of memory consolidation. Proceedings of the National Academy of Sciences of the United States of America 107: 5605-5610.
50. Chung SH, Franceschi S, Lambert PF, (2010) Estrogen and ERalpha: culprits in cervical cancer? Trends in endocrinology and metabolism: TEM 21: 504-511.
51. Forte A, Schettino MT, Finicelli M, Cipollaro M, Colacurci N, et al. (2009) Expression pattern of stemness-related genes in human endometrial and endometriotic tissues. Molecular medicine 15: 392-401.
52. Kalantari M, Lee D, Calleja-Macias IE, Lambert PF, Bernard HU, (2008) Effects of cellular differentiation, chromosomal integration and 5-aza-2′-deoxycytidine treatment on human papillomavirus-16 DNA methylation in cultured cell lines. Virology 374: 292-303.
53. Jackson K, Soutto M, Peng D, Hu T, Marshal D, et al. (2011) Epigenetic silencing of somatostatin in gastric cancer. Dig Dis Sci 56: 125-130.
54. Al-Romaih K, Sadikovic B, Yoshimoto M, Wang Y, Zielenska M, et al. (2008) Decitabine-induced demethylation of 5′ CpG island in GADD45A leads to apoptosis in osteosarcoma cells. Neoplasia 10: 471-480.
55. Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, et al. (2006) DNA methylation profiling of human chromosomes 6, 20 and 22. Nature genetics 38: 1378-1385.
56. Nabilsi NH, Broaddus RR, Loose DS, (2009) DNA methylation inhibits p53-mediated survivin repression. Oncogene 28: 2046-2050.
57. Kim TW, Kim YJ, Lee HJ, Min SY, Kang HS, et al. (2010) Hs.137007 is a novel epigenetic marker hypermethylated and up-regulated in breast cancer. International journal of oncology 36: 1105-1111.
58. Cox GS, Gutkin DW, Haas MJ, Cosgrove DE, (1998) Isolation of an Alu repetitive DNA binding protein and effect of CpG methylation on binding to its recognition sequence. Biochimica et biophysica acta 1396: 67-87.
59. Hietanen S, Lain S, Krausz E, Blattner C, Lane DP, (2000) Activation of p53 in cervical carcinoma cells by small molecules. Proceedings of the National Academy of Sciences of the United States of America 97: 8501-8506.
60. Hantusch B, Kalt R, Krieger S, Puri C, Kerjaschki D, (2007) Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells. BMC molecular biology 8: 20.